Roundview Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History

Roundview Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $219,004 - $257,022	-368 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $19,021 - $23,483	35 Added 10.51%	368 $232,000
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $297,921 - $353,418	-519 Reduced 60.92%	333 $202,000
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $367,535 - $429,408	852	852 $418,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Roundview Capital LLC with notifications on news.